Effects of the Menstrual Cycle on Triceps Surae Properties in Women

NCT ID: NCT06214442

Last Updated: 2024-06-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-10

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The menstrual cycle is an important biological rhythm, whereby large cyclic fluctuations in endogenous sex hormones, such as estrogen and progesterone, are observed, which can affect performance. Evidence shows that endogenous and exogenous changes in hormone concentrations during the menstrual cycle exert many effects on the nervous and endocrine systems, in addition to the connective tissue, with consequences for the movement system. Pre-clinical studies (i.e., in animal models) show an estrogen association with the structural and mechanical properties of tendons and ligaments. Several elegant studies performed with female participants have tried to establish the mechanism underlying the effect of estrogen on collagen synthesis and its effects on exercise and functionality. Their findings suggest that the tendon properties may be affected when exposed to varying concentrations of estrogen. The largest tendon in humans, the Achilles tendon, has a direct role in functional capacity, activities of daily living, and locomotion. Studies show that the triceps surae's structural and mechanical properties may change throughout the menstrual cycle, and that these changes are related to endogenous and exogenous fluctuations in estrogen and progesterone. Musculotendinous stiffness, which is dependent on the collagen content, has been seen to vary considerably over the course of the menstrual cycle. In addition, it has been reported that females who have been taking the contraceptive pill for at least a year demonstrate lower levels of tendon strain compared to non-pill taking females, indicating a possible influence of hormonal state on tendon mechanical properties. However, the different experimental designs, the varied approaches to the evaluations and the lack of studies with high methodological quality limit our understanding of the effects of the different phases of the menstrual cycle on the triceps surae's neuromechanical properties. The aim of this observational study will be to investigate whether the morphological, mechanical (active and passive), material, and functional properties of the plantar flexor muscles and of the Achilles tendon, as well as functional parameters, change during voluntary contractions throughout the phases of the menstrual cycle in eumenorrheic women and in users of hormonal contraception. Understanding the acute effects of these properties in eumenorrheic women and users of hormonal contraception is essential so that we can adequately plan interventions and prescriptions of physical exercise and rehabilitation aimed for women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menstrual Cycle Achilles Tendon

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Physically active eumenorrheic women with regular menstrual cycle

Women who practice physical exercise and have regular menstruation ranging from 25 to 38 days.

Evaluations of the mechanical properties of the achilles tendon in different phases of the menstrual cycle

Intervention Type OTHER

Monitoring assessments to verify the effect of different phases of the menstrual cycle on the neuromechanical properties of the Achilles tendon.

Sedentary eumenorrheic women with regular menstrual cycle

Women who do not practice physical exercise and have regular menstruation ranging from 25 to 38 days.

Evaluations of the mechanical properties of the achilles tendon in different phases of the menstrual cycle

Intervention Type OTHER

Monitoring assessments to verify the effect of different phases of the menstrual cycle on the neuromechanical properties of the Achilles tendon.

Physically active women using hormonal contraceptives

Physically active women using oral hormonal contraception combined with estrogen and progesterone within the last six months.

Evaluations of the mechanical properties of the achilles tendon in different phases of the menstrual cycle

Intervention Type OTHER

Monitoring assessments to verify the effect of different phases of the menstrual cycle on the neuromechanical properties of the Achilles tendon.

Sedentary women who use hormonal contraception

Sedentary women using oral hormonal contraception combined with estrogen and progesterone within the last six months.

Evaluations of the mechanical properties of the achilles tendon in different phases of the menstrual cycle

Intervention Type OTHER

Monitoring assessments to verify the effect of different phases of the menstrual cycle on the neuromechanical properties of the Achilles tendon.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Evaluations of the mechanical properties of the achilles tendon in different phases of the menstrual cycle

Monitoring assessments to verify the effect of different phases of the menstrual cycle on the neuromechanical properties of the Achilles tendon.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being eumenorrheic with a regular menstrual cycle lasting between 21 and 35 days during the last 6 months prior to study participation.
* Body Mass Index between 20 and 25 kg/m2.
* Normal ankle function and range of motion.
* Do not use hormonal contraception of any kind or supplements hormones for at least the 6 months prior to the study.
* No complaints of pain or history of lower limb injury.
* For the physically active group, practice regular physical exercise at least 3 times a week for the past 6 months.
* For the sedentary group, not practicing regular physical exercise in the last 6 months.


* Body Mass Index between 20 and 25 kg/m2.
* Normal ankle function and range of motion.
* Make use of any method of oral hormonal contraception (compressed).
* Make use of combined oral hormonal contraception with estrogen and progesterone (ethinylestradiol + Drospirenone) for at least 6 months before participating in the study.
* Do not use other hormone supplements for at least 6 months prior to the study.
* No complaints of pain or presence of pathologies in the lower limb
* For the physically active group, practice regular physical exercise at least 3 times a week for the past 6 months.
* For the sedentary group, not practicing regular physical exercise in the last 6 months

Exclusion Criteria

Health problems - contraindication to maximal effort exercise. Additionally, the following subjects will be excluded:

* Women who have anovulatory cycles or phase lutea deficiency.
* Women in early menopause.
* Pregnant or lactating women.
* Women with oligomenorrhea (menstrual cycles longer than 35 days, or delay of menstruation for the same period).
* Women with hypothalamic amenorrhea.
* Female smokers.
* Women with metabolic syndrome.
* For women using hormonal contraceptives, women who use adhesive, injectable, intrauterine devices, implants, vaginal rings, as well as progesterone-only CH methods.
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Marco Aurélio Vaz, PhD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marco Aurélio Vaz, PhD

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marco Vaz

Role: STUDY_CHAIR

Federal University of Rio Grande do Sul

Marco Vaz

Role: STUDY_DIRECTOR

Federal University of Rio Grande do Sul

Marco Vaz

Role: PRINCIPAL_INVESTIGATOR

Federal University of Rio Grande do Sul

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Marco Aurelio Vaz

Porto Alegre, , Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marco Vaz

Role: CONTACT

5551993851188

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marco VAZ

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5.989.983

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Resistance Training in Knee Osteoarthritis
NCT01099371 UNKNOWN PHASE2/PHASE3